[By NBC-1TV H. J Yook]ResearchDx, LLC of Irvine, California, USA today announced its sponsorship and attendance at the Asia BioPharm 2014 Convention in Singapore as part of its focus on the important Asian biopharmaceutical and diagnostics markets.

ResearchDx will be presenting at the Asia BioPharma Convention 2014 Meeting in Singapore, held March 10th-13th. “We are proud to be involved as a sponsor of the BioPharma Asia Convention 2014 meeting. This meeting brings together the key diagnostics and biopharmaceutical companies in the region and is the ideal venue to highlight our services,” said Dr. Philip Cotter, Principal and Co-Founder of ResearchDx.

As a Contract Diagnostics Organization, ResearchDx is targeting two major areas for Asian clients. “We can provide a strategic partnership to Asian companies looking to develop companion diagnostics or in vitro diagnostic products for the local, US or European markets. We provide a full range of companion diagnostics and in vitro diagnostics services,” said Dr. Mathew Moore, Co-Founder and Principal at ResearchDx.

In addition, ResearchDx provides comprehensive services to assist International Clinical Laboratories obtain US CLIA certification, as well as various additional Clinical Laboratory accreditations such as ISO or College of American Pathologists (CAP). “International CLIA certification, and ISO or CAP accreditation provides our clients with a competitive edge. These licensures have enabled our clients to successfully compete for multi-national based clinical trial studies,” said Dr. Philip Cotter.